SCHEMBL24467470

SCHEMBL24467470

CC(C)(C)n1nc(-c2ccc3cc(C(O)NC4CCC4)[nH]c3c2)c2c(N)ncnc21

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 20/20 0.69
▸ KDR P35968 19/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25858431 0.86 RET (0.70) RETKDR
SCHEMBL25858443 0.84 RET (0.70) RETKDR
SCHEMBL24744024 0.84 RET (0.72) RETKDR
SCHEMBL25858381 0.83 RET (0.69) RETKDR
SCHEMBL24467467 0.83 RET (0.70) RETKDR
SCHEMBL25858524 0.83 RET (0.69) RETKDR
SCHEMBL25858507 0.83 RET (0.69) RETKDR
SCHEMBL25858477 0.83 RET (0.70) RETKDR
SCHEMBL25858435 0.83 RET (0.69) RETKDR
SCHEMBL25858394 0.83 RET (0.69) RETKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609898-B1 COMPOUNDS USEFUL AS RET INHIBITORS CANCER RESEARCH TECH LTD (GB) 2022-06-01 — — EP disclosed
Send feedback